HeartSciences (HSCS) Total Debt (2022 - 2026)

HeartSciences (HSCS) has reported Total Debt for 5 consecutive years, with $3.1 million the latest figure, recorded in Q2 2026.

• Quarterly Total Debt rose 52.21% year-over-year to $3.1 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $3.1 million (up 52.21% YoY) and the FY2026 annual result came in at $3.1 million, up 52.21% from the prior year.
• Total Debt improved to $3.1 million in Q2 2026 per HSCS's latest filing, from $2.1 million in the prior quarter.
• Over the last five years, Total Debt for HSCS reached as high as $4.4 million in Q2 2022 and fell as low as $49470.0 in Q4 2024.
• A 5-year average of $1.5 million and a median of $1.0 million in 2022 frame the typical range for Total Debt.
• Annual changes were most pronounced in 2023 — Total Debt tumbled 88.74% — and 2026, when it surged 52.21%.
• Year by year, Total Debt stood at $1.0 million in 2022, then tumbled by 50.0% to $500000.0 in 2023, then tumbled by 90.11% to $49470.0 in 2024, then surged by 4046.29% to $2.1 million in 2025, then soared by 52.21% to $3.1 million in 2026.
• According to Business Quant data, Total Debt over the past three periods registered $3.1 million, $2.1 million, and $49470.0 for Q2 2026, Q2 2025, and Q4 2024 respectively.